NATIONAL BANK OF CANADA /FI/ - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 144 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,686
+37.7%
1,8000.0%0.00%
Q2 2023$5,580
+123.0%
1,8000.0%0.00%
Q1 2023$2,502
-29.8%
1,8000.0%0.00%
Q4 2022$3,564
-10.9%
1,8000.0%0.00%
Q3 2022$4,000
-33.3%
1,8000.0%0.00%
Q2 2022$6,000
-14.3%
1,8000.0%0.00%
Q1 2022$7,000
-22.2%
1,8000.0%0.00%
Q4 2021$9,0001,8000.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$90,819,89014.58%
Eversept Partners, LP 2,644,988$11,161,8490.94%
TPG GP A, LLC 12,328,767$52,027,3970.90%
Nantahala Capital Management 2,212,757$9,337,8350.80%
Rubric Capital Management LP 4,024,500$16,983,3900.64%
Hedges Asset Management LLC 84,600$357,0120.31%
Signature Wealth Management Partners, LLC 66,666$281,3310.28%
Tejara Capital Ltd 96,672$407,9560.23%
Tranquilli Financial Advisor LLC 71,414$301,3670.22%
EAM Investors, LLC 230,271$971,7440.19%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders